ACE-031 is among the peptides researched in the context of the growth hormone (GH) axis. Acts as a decoy receptor that binds and sequesters myostatin and related TGF-beta superfamily ligands, preventing them from binding native ActRIIB on muscle cells — blocking myostatin's growth-inhibitory signaling.
Historically studied as a myostatin-pathway inhibitor for muscle-wasting conditions; today referenced mainly as a cautionary case study in off-target toxicity from cross-reactivity with related BMP ligands.
Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.
Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.
Numerous preclinical and some clinical studies exist on the GH axis, with evidentiary strength varying by substance.
References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.
We reply personally – via email or Telegram.